Filing Details

Accession Number:
0000939767-25-000035
Form Type:
4
Zero Holdings:
No
Publication Time:
2025-02-26 20:00:50
Reporting Period:
2025-02-24
Filing Date:
2025-02-26
Accepted Time:
2025-02-26 20:00:50
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
939767 Exelixis Inc. EXEL Biological Products, (No Disgnostic Substances) (2836) 043257395
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1959132 Dana Aftab C/O Exelixis, Inc.
1851 Harbor Bay Parkway
Alameda CA 94502
Cso/Evp Disc & Trans Research No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2025-02-24 26,987 $36.75 511,908 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 5,835 Indirect By 401(k)
Footnotes
  1. Includes 259,043 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs"). Each RSU is the economicequivalent of one share of Common Stock.
  2. Represents shares of Common Stock under the Exelixis, Inc. 401(k) Plan, pursuant to a plan statement dated as of February 24, 2025.